VJHemOnc Podcast Focus on MRD: current landscape and future questions in hemonc
Jul 4, 2018
Experts from various institutions discuss Measurable Residual Disease (MRD) in the field of hemonc. They explore the role of MRD as a prognostic factor, novel technologies for MRD detection, and MRD measurement as a strategy for treatment-free survival. Recorded at several conferences, this podcast dives into the exciting realm of MRD in cancer management.
Chapters
Transcript
Episode notes
1 2 3 4 5
Introduction
00:00 • 4min
Importance of MRD as a Prognostic Factor in Leukemia and its Role in Treatment Protocols
03:58 • 2min
Molecular MRD Detection and the Future of Leukemia Treatment
05:43 • 2min
Comparison of Next-Generation Sequencing and Flow Cytometry for MRD Detection
07:40 • 2min
The Future of Minimal Residual Disease (MRD) and Treatment-Free Survival
10:00 • 2min